MALIHA AMJED: Open Payments
NPI 1700499969 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 37 payments from 15 companies in 2025. Trend: 2023 $438 · 2024 $695 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $140 |
| Novo Nordisk Inc | 4 | $79 |
| Alnylam Pharmaceuticals Inc. | 4 | $74 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Philips North America LLC | 2 | $48 |
| ABIOMED | 1 | $40 |
| AtriCure, Inc. | 1 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: LEQVIO, Wegovy, ONPATTRO, LifeVest, WAINUA, JARDIANCE, ATRICLIP LAA EXCLUSION SYSTEM, Extended Holter.
Industry payments across VA — which companies pay providers there.
